{"transactions":[{"id":3168918,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX","position":1,"cik":"0001534120","reported_name":"Cerecor Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Convertible Preferred Stock","published_at":"2020-04-27T13:30:50.000Z","date":"2020-04-10","kind":"exercise","acquired":false,"shares":9805845,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Shares of the Issuer's convertible preferred stock were convertible into shares of the Issuer's common stock upon the expiration of the Reporting Person's Lock-Up Agreement with the Issuer, which was accelerated, on a one-for-one basis at the option of the Reporting Person upon distribution to the Reporting Person's stockholders or upon a sale. The convertible preferred stock has no expiration date."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Shares of the Issuer's convertible preferred stock were convertible into shares of the Issuer's common stock upon the expiration of the Reporting Person's Lock-Up Agreement with the Issuer, which was accelerated, on a one-for-one basis at the option of the Reporting Person upon distribution to the Reporting Person's stockholders or upon a sale. The convertible preferred stock has no expiration date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F1","text":"Shares of the Issuer's convertible preferred stock were convertible into shares of the Issuer's common stock upon the expiration of the Reporting Person's Lock-Up Agreement with the Issuer, which was accelerated, on a one-for-one basis at the option of the Reporting Person upon distribution to the Reporting Person's stockholders or upon a sale. The convertible preferred stock has no expiration date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":9805845},"source":{"system":"sec-edgar","filing":"0001578563-20-000020","document":"primary_doc.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000157856320000020/primary_doc.xml","form_type":"4"}},{"id":3168917,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX","position":1,"cik":"0001534120","reported_name":"Cerecor Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-04-27T13:30:50.000Z","date":"2020-04-15","kind":"sale","acquired":false,"shares":92777,"price":1.5531,"value":144091.9587,"ownership":{"direct":true},"balance_after":9713068,"source":{"system":"sec-edgar","filing":"0001578563-20-000020","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000157856320000020/primary_doc.xml","form_type":"4"}},{"id":3168916,"issuer":{"id":7560,"kind":"organization","name":"AYTU BIOPHARMA, INC"},"owners":[{"id":4936,"kind":"organization","name":"Avalo Therapeutics, Inc.","symbol":"AVTX","position":1,"cik":"0001534120","reported_name":"Cerecor Inc.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-04-27T13:30:50.000Z","date":"2020-04-10","kind":"exercise","acquired":true,"shares":9805845,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Shares of the Issuer's convertible preferred stock were convertible into shares of the Issuer's common stock upon the expiration of the Reporting Person's Lock-Up Agreement with the Issuer, which was accelerated, on a one-for-one basis at the option of the Reporting Person upon distribution to the Reporting Person's stockholders or upon a sale. The convertible preferred stock has no expiration date."}],"balance_after":9805845,"source":{"system":"sec-edgar","filing":"0001578563-20-000020","document":"primary_doc.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1385818/000157856320000020/primary_doc.xml","form_type":"4"}}]}